|
1
|
Hoffman JI and Kaplan S: The incidence of
congenital heart disease. J Am Coll Cardiol. 39:1890–1900. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Debrus S, Berger G, de Meeus A, et al:
Familial non-syndromic conotruncal defects are not associated with
a 22q11 microdeletion. Hum Genet. 97:138–144. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jenkins KJ, Correa A, Feinstein JA, et al:
The American Heart Association Council on Cardiovascular Disease in
the Young: Noninherited risk factors and congenital cardiovascular
defects: current knowledge: a scientific statement from the
American Heart Association Council on Cardiovascular Disease in the
Young: endorsed by the American Academy of Pediatrics. Circulation.
115:2995–3014. 2007.
|
|
4
|
Cooper WO, Hernandez-Diaz S, Arbogast PG,
et al: Major congenital malformations after first-trimester
exposure to ACE inhibitors. N Engl J Med. 354:2443–2451. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Goldmuntz E, Clark BJ, Mitchell LE, et al:
Frequency of 22q11 deletions in patients with conotruncal defects.
J Am Coll Cardiol. 32:492–498. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu YJ, Wang J, Xu R, et al: Detecting
22q11.2 deletion in Chinese children with conotruncal heart defects
and single nucleotide polymorphisms in the haploid TBX1 locus. BMC
Med Genet. 12:1692011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Morrisey EE, Tang Z, Sigrist K, et al:
GATA6 regulates HNF4 and is required for differentiation of
visceral endoderm in the mouse embryo. Genes Dev. 12:3579–3590.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao R, Watt AJ, Battle MA, Li J, Bondow
BJ and Duncan SA: Loss of both GATA4 and GATA6 blocks cardiac
myocyte differentiation and results in acardia in mice. Dev Biol.
317:614–619. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lepore JJ, Mericko PA, Cheng L, Lu MM,
Morrisey EE and Parmacek MS: GATA-6 regulates semaphorin 3C and is
required in cardiac neural crest for cardiovascular morphogenesis.
J Clin Invest. 116:929–939. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kodo K, Nishizawa T, Furutani M, et al:
GATA6 mutations cause human cardiac outflow tract defects by
disrupting semaphorin-plexin signaling. Proc Natl Acad Sci USA.
106:13933–13938. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sprenkle AB, Murray SF and Glembotski CC:
Involvement of multiple cis elements in basal- and alpha-adrenergic
agonist-inducible atrial natriuretic factor transcription. Roles
for serum response elements and an SP-1-like element. Circ Res.
77:1060–1069. 1995. View Article : Google Scholar
|
|
12
|
Bamforth SD, Bragança J, Eloranta JJ, et
al: Cardiac malformations, adrenal agenesis, neural crest defects
and exencephaly in mice lacking Cited2, a new Tfap2 co-activator.
Nat Genet. 29:469–474. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lin X, Huo Z, Liu X, et al: A novel GATA6
mutation in patients with tetralogy of Fallot or atrial septal
defect. J Hum Genet. 55:662–667. 2010. View Article : Google Scholar
|
|
14
|
Burch JB: Regulation of GATA gene
expression during vertebrate development. Semin Cell Dev Biol.
16:71–81. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brewer A and Pizzey J: GATA factors in
vertebrate heart development and disease. Expert Rev Mol Med.
8:1–20. 2006. View Article : Google Scholar
|
|
16
|
Barillot W, Tréguer K, Faucheux C, Fédou
S, Thézé N and Thiébaud P: Induction and modulation of smooth
muscle differentiation in Xenopus embryonic cells. Dev Dyn.
237:3373–3386. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stoller JZ and Epstein JA: Cardiac neural
crest. Semin Cell Dev Biol. 16:704–715. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brown CB, Feiner L, Lu MM, et al: PlexinA2
and semaphorin signaling during cardiac neural crest development.
Development. 128:3071–3080. 2001.PubMed/NCBI
|
|
19
|
Yang H, Lu MM, Zhang L, Whitsett JA and
Morrisey EE: GATA6 regulates differentiation of distal lung
epithelium. Development. 129:2233–2246. 2002.PubMed/NCBI
|
|
20
|
Fischer A, Klattig J, Kneitz B, et al: Hey
basic helix-loop-helix transcription factors are repressors of
GATA4 and GATA6 and restrict expression of the GATA target gene ANF
in fetal hearts. Mol Cell Biol. 25:8960–8970. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Suzuki E, Evans T, Lowry J, Truong L, Bell
DW, Testa JR and Walsh K: The human GATA-6 gene: structure,
chromosomal location, and regulation of expression by
tissue-specific and mitogen-responsive signals. Genomics.
38:283–290. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mano T, Luo Z, Malendowicz SL, Evans T and
Walsh K: Reversal of GATA-6 downregulation promotes smooth muscle
differentiation and inhibits intimal hyperplasia in balloon-injured
rat carotid artery. Circ Res. 84:647–654. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Morrisey EE: GATA-6: the proliferation
stops here: cell proliferation in glomerular mesangial and vascular
smooth muscle cells. Circ Res. 87:638–640. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Maitra M, Koenig SN, Srivastava D and Garg
V: Identification of GATA6 sequence variants in patients with
congenital heart defects. Pediatr Res. 68:281–285. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Loffredo CA, Hirata J, Wilson PD, Ferencz
C and Lurie IW: Atrioventricular septal defects: possible etiologic
differences between complete and partial defects. Teratology.
63:87–93. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li H, Cherry S, Klinedinst D, et al:
Genetic modifiers predisposing to congenital heart disease in the
sensitized Down syndrome population. Circ Cardiovasc Genet.
5:301–308. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guo Y, Shen J, Yuan L, Li F, Wang J and
Sun K: Novel CRELD1 gene mutations in patients with
atrioventricular septal defect. World J Pediatr. 6:348–352. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Joziasse IC, Smith KA, Chocron S, et al:
ALK2 mutation in a patient with Down’s syndrome and a congenital
heart defect. Eur J Hum Genet. 19:389–393. 2011.PubMed/NCBI
|
